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 ABSTRACT 
Thyrotoxic hypokalemic periodic paralysis is a medical emergency which presents with muscular weakness, hypokalemia and 
features of thyrotoxicosis. Urgent treatment is very important; since, very low potassium levels can lead to cardiac 
complications. Here, we present a case where features of hyperthyroidism were missed on initial assessment and were picked 
up subsequently in the second presentation of paralysis. This emphasizes the importance in recognizing the subtle features of 
hyperthyroidism from both history and clinical examination. Acute management consisted of administering intravenous 
potassium chloride and then treatment of thyrotoxicosis. 
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hyrotoxic hypokalemic periodic paralysis (THPP) 
is an acquired form of periodic paralysis that 
presents occasionally to the emergency 
department. It encompasses of hypokalemia, features of 
thyrotoxicosis and periodic paralysis [1-3]. Immediate 
correction is very imminent since it can predispose to 
cardiac arrhythmias, precipitated by low potassium levels. 
There is a paucity of reports on this disorder from India; 
therefore, we present such a case of THPP in a 38 year old 
man [4]. Because of its rare presentation, the emergency 
physician should be well versed in identifying the 
condition and treating it, thus preventing complications. 
CASE REPORT 
A 38-year-old man presented to the emergency department 
(ED) in the morning with complaints of weakness in both 
the lower limbs, inability to walk, mild breathing difficulty 
and lack of sleep. The night prior to presentation, he had 
consumed alcohol along with a carbohydrate diet and went 
to bed. Early morning around 2.00 AM, he woke up and 
observed that he was unable to flex his knees but could roll 
his lower limbs from side to side. He noticed mild 
breathing difficulty and he was able to move his upper 
extremities well. He also gave a history of heat intolerance 
and loss of weight since the past one month. His wife also 
told that she has been noticing his eyeballs to be prominent 
since the last weeks.  
There was no history of fever, trauma, family history 
or any new drug intake. He had recently returned from 
abroad, where he used to work as a manual laborer. He had 
a similar history back there. He was taken to the hospital 
and was told his condition is due to low potassium levels. 
Correction was given and discharged with oral potassium 
chloride (KCl) tablets. On reaching his home here in India, 
noticing improvement and no further deficit, he had 
stopped taking the KCl tablets since the last few days.  
On physical examination, he was conscious, afebrile, 
anxiously looking and had exophthalmos bilaterally. His 
pulse rate was 90/min, regular and good volume, 
respiratory rate was 22 breaths /min and blood pressure 
was 140/70 mm Hg in the right arm in supine position. 
Rest of the respiratory and cardiovascular system 
examinations was normal. On neurological examination, 
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higher mental functions and cranial nerves were normal. 
He had fine tremors of both hands with proximal weakness 
in both the lower limbs and diminished tendon reflexes 
bilaterally. Powers at all joints in upper limb were 5/5 
while it was grade 3/5 at both hip and grade 4/5 at knee 
and ankle joints. Sensory system and cerebellar functions 
were normal. Examination of neck revealed diffuse goitre. 
His laboratory profile at presentation is shown in Table 1. 
Table 1 - Results of Initial Laboratory Studies  
Spot urine potassium was 9 mmol/L (a low urine 
potassium level is <20 mmol/L). Thyroid profile was 
suggestive of hyperthyroidism i.e. free T3 - 11.5 pmol/L 
(normal 4-8.3 pmol/L), free T4 - 24.7 pmol/L (normal 9-
20 pmol/L) and TSH - 0.03 μIU/ml (normal 0.2-5 μIU/ml). 
X-ray chest was normal. Ultrasonography of thyroid 
revealed enlarged thyroid gland with mild increase in color 
flow which could represent toxic goitre. ECG showed 
flattened T waves in lateral leads. In view of documented 
hypokalemia, lower limb weakness and features of 
thyrotoxicosis, a diagnosis of thyrotoxic hypokalemic 
periodic paralysis was made.  
The patient was started on intravenous potassium 
chloride (KCl) and he improved dramatically in the ED 
itself. The patient was then shifted to the ward, where 
repeat blood test showed improved potassium level to 4.26 
mmol/L (normal value – 3.5 to 4.5 mmol/L). He was also 
started on Propranolol and Carbimazole. With 
improvement in symptoms, he was discharged after three 
days on Propranolol and Carbimazole to review after two 
weeks. 
DISCUSSION  
Thyrotoxic hypokalemic periodic paralysis is a rare but 
potentially lethal manifestation of hyperthyroidism which 
is characterized by muscular weakness due to intracellular 
shift of potassium and subsequent hypokalemia [1]. 
Patients with this type of paralysis have an inherent defect 
in Na
+
-K
+
 ATPase activity which is sensitive to thyroid 
hormone. The thyroid hormone alters the cell membrane 
permeability to potassium through Na
+
-K
+
 ATPase pump 
leading to intracellular shift of potassium resulting in 
hypokalemic periodic paralysis without depleting the total 
body K
+
 (potassium) stores [2].  
THPP is more commonly reported in Oriental Asians 
in the age group of 20-40 years. Paralysis occurs only 
when the patient is at rest, and usually in bed at night. The 
attacks of paralysis vary widely in severity and range from 
weakness of the muscles of the pelvic girdle, lasting 
several hours, to a total paralysis of all the muscles from 
the neck downward, lasting up to 48 hours [3]. Proximal 
muscles are affected more severely than distal muscles [3].  
Various precipitating factors include trauma, infection, 
emotional upset, menstruation, epinephrine, thyroid 
hormone, steroids, carbohydrate intake and unaccustomed 
exercise [5]. The majority of cases of hyperthyroidism 
associated with THPP are due to Grave’s disease although 
other conditions including thyroiditis, toxic multi-nodular 
goitre, toxic adenoma, TSH secreting pituitary tumor, 
ingestion of T4 and inadvertent iodine excess have also 
been implicated [6].   
Lin et al advocated the use of spot urine for K
+
 
excretion rate and evaluation of blood acid-base status in 
the diagnosis and management. A very low rate of K
+
 
excretion coupled with the absence of a metabolic acid-
base disorder suggests HPP, whereas a high rate of K
+
 
excretion accompanied by either metabolic alkalosis or 
metabolic acidosis favors non-HPP. The presence of 
features of hyperthyroidism along with low potassium 
excretion and normal acid base status points towards 
THPP [7]. 
During periodic paralysis and marked hypokalemia, 
immediate supplementation with KCl is warranted to 
prevent major cardiac complications. KCl is given slow IV 
or orally or both. While treating with KCl, it should be 
kept in mind that the hypokalemia seen in THPP is due to 
  Laboratory Tests Results Normal 
pH 7.368 7.35-7.45 
pO2  (mm Hg) 79.5 83.0-108.0 
pCO2  (mm Hg) 38.0 35.0-48.0 
cHCO3
-
  (mmol/L) 21.9 21.0-28.0 
Sodium (mmol/L) 141 138-146 
Potassium (mmol/L) 2.1 3.5-4.5 
Calcium (mmol/L) 1.3 1.15-1.33 
Hematocrit (%) 42 38-51 
Hemoglobin (g/dL) 14.3 12-17 
Lactate (mmol/L) 1.21 0.56-1.39 
WBC Count (cells/mm
3
) 10300 4000-10000 
Platelets (lakhs/cumm) 3.1 1-3 
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sudden intracellular shift of K
+
 and not due to K
+
 
deficiency. Therefore, clinicians should exercise caution 
when administering high-dose K
+
 supplementation as 
rebound hyperkalemia can also occur [8].  
Oral or IV propranolol, a nonspecific-adrenergic 
blocker, has also been proposed as an alternative treatment 
to ameliorate symptoms. The common recommendation is 
that KCl supplementation dose should be <10 mEq/hr with 
close monitoring of serum potassium levels to avoid 
rebound hyperkalemia [9]. Use of potassium supplements 
is not useful for prophylaxis against further paralytic 
attacks and should not be given to patients between 
attacks. Because THPP does not recur once the patient is 
euthyroid, adequate control of hyperthyroidism is the 
mainstay of therapy. The cause for the hyperthyroidism 
should also be identified [10]. 
CONCLUSION 
The diagnosis of THPP is often delayed partially due to 
the subtle features of thyrotoxicosis and partially due to 
unawareness of this condition because of its relative rarity. 
Hypokalemia with paralysis has got many differential 
diagnoses. Excluding family history and including features 
of hyperthyroidism and also checking for low urine 
potassium excretion will give a definite diagnosis of 
THPP. The aim of treatment is to correct hypokalemia and 
later to achieve a euthyroid state.   
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